Company: MDCXW
Filing Date: 2025-03-28
Form Type: 253G2
Source: 0001062993-25-006502
Chunk: 153

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-28
Form: 253G2
Chunk 153
---
 "material non-nonpublic information" (collectively "material information") about the reporting issuer or its securities that has not been generally disclosed (known as "insider trading"). The definitions of "material fact" and "material change" are based on a market impact test in that the fact or change would (or would reasonably be expected to) significantly affect the market price or value of a security. Under U.S. insider trading rules, information is material if there is a substantial likelihood that a reasonable shareholder would consider it important in making an investment decision, to fulfill the materiality requirement, there must be a substantial likelihood that a fact would have been viewed by the reasonable investor as having significantly altered the 'total mix' of information made available and information is nonpublic if it has not been disseminated in a manner making it available to investors generally. Examples of potentially material information include:

(i)changes in the ownership of securities that may affect control of the reporting issuer;

(ii)changes in the corporate structure of the reporting issuer, such as reorganizations or amalgamations;

(iii)take-over bids or issuer bids;

<div align='center'>-2-</div>

(iv)major acquisitions or dispositions;

(v)changes in capital structure;

(vi)significant borrowings;

(vii)public or private sales of additional securities;

(viii)developments affecting the resources of the reporting issuer, including exploration discoveries;

(ix)entering into or the loss of significant contracts;

(x)a material increase or decrease in near term earnings prospects;

(xi)changes in capital investment plans or objectives;

(xii)significant changes in management;

(xiii)material litigation; and

(xiv)events of default under financing or other agreements.

2.2The prohibition on trading applies not only to trading in the securities of the reporting issuer but also to trading in the securities of another reporting issuer if the person wishing to trade possesses undisclosed material information about that reporting issuer (for example, a reporting issuer that the other reporting issuer is doing business with).

2.3Securities laws also prohibit "tipping", defined as communicating non-public material information, other than in the necessary course of business, to another person. All directors, officers and other employees of the Company must ensure that they do not divulge such non- public information to any unauthorized person, whether or not such person may trade on the information. It is the duty of all persons to whom this Policy applies to maintain the confidentiality of material non-public information belonging or relating to the Company. Non-public information belonging